Charlesson LLC.

Charlesson LLC. (Charlesson) is an early stage pharmaceutical company, engaged in the development of drugs for the treatment of retinal diseases. The company works with a targeted approach towards its drug development starting with this under served market. The key areas in which the company operates are diabetic macular edema (DME) and age-related macular degeneration (AMD). In addition, Charlesson also owns a world class contract research organization (CRO), through which it provides large and small companies alike many unique animal models and assays at affordable prices. CLT-003 is the lead product of the company, which is considered to be a sustained release treatment for DME, for which no therapeutics is currently approved. Charlesson is headquartered in Oklahoma, the US.

Street: 
800 Research Parkway
City: 
Oklahoma City
Postcode: 
73104
Federal State : 
United States
WebSite: 
www.charlessonllc.com
Fax: 
1-405-2712554

Company Index Score

Current Index Score Historical Index Score
  • Charlesson LLC. currently scores 50 % in the index.
  • Charlesson LLC. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Charlesson LLC. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets